{"basic_info": {"ticker": "600080", "exchange": "XSHG", "bloomberg_ticker": "600080 CH Equity", "name": "GINWA ENTERPRISE GROUP INC-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "金花股份", "period": "2020", "market_value": 2079115520, "total_income": 754544013, "ccy": "人民币元", "shariah_compliance_summary": "unknown"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 634713402, "business_income_over_total_income": 0.8411880434600969}, {"shariah_compliance": "unknown", "income": 119830609, "business_income_over_total_income": 0.1588119538892955}], "details": [{"business_activity_cn": "骨科类", "business_activity_en": "Orthopedic class", "income": 521374134, "business_income_over_total_income": 0.6909790880548674, "shariah_compliance": "compliant"}, {"business_activity_cn": "免疫类", "business_activity_en": "Immunology", "income": 51243872, "business_income_over_total_income": 0.06791369504909185, "shariah_compliance": "compliant"}, {"business_activity_cn": "儿童类", "business_activity_en": "Children", "income": 16994824, "business_income_over_total_income": 0.02252330375325634, "shariah_compliance": "compliant"}, {"business_activity_cn": "普药类", "business_activity_en": "Class generics", "income": 45100572, "business_income_over_total_income": 0.059771956602881426, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 1154212, "business_income_over_total_income": 0.0015296814766456838, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 118676397, "business_income_over_total_income": 0.15728227241264983, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": NaN, "shariah_compliance": "compliant", "amount_over_market_value": NaN}]}